Diabetes Complications

Name PI
A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Event (DEVOTE) Margaret Lo, M.D.

 

Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 Diabetes Demetra Christou, Ph.D.

 

Non-Alcoholic Fatty Liver Disease in Gestational Diabetes

Sattari, Maryam, M.D.

 

SONAR: Study Of Diabetic Nephropathy with Atrasentan Karen Hall, M.D.

 

A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment with BELVIQ (lorcaserin HCI) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects with Cardiovascular Disease or Multiple Cardiovascular Risk Factors CAMELLIA Dominick J. Angiolillo, M.D., Ph.D.

 

A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects with Type 2 Diabetes at High Risk of Cardiovascular Events Joe Chehade, M.D.

 

A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesion (ABSORB III)